EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking, Dynamics, and Cytotoxicity Assessment of Pyrazolo[1,5‐ a ]pyrimidine Derivatives Against Breast Cancer

Gaurav Patel, Rizwan Ghumara, Sagarkumar Patel, Pranaykumar Shah, Niyati Patel, Nitin Lunagariya, Purvi Shah, Suraj Mali, Mehul Patel, Umang Shah iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Gaurav Patel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shree M. M. Patel institute of Science and Research, Kadi Serva Vishwavidyalaya, Gandhinagar, India. Hauptthemen laut MEDLINE: Pyrimidines, Pyrazoles, Antineoplastic Agents, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A number of pyrazolo[1,5‐ a ]pyrimidine derivatives were effectively synthesized and described in this work and their biological activity has been checked against MCF‐7, breast cancer cell line. All synthesized compounds were confirmed by mass and 1 H and 13 C NMR spectroscopic techniques. In addition, the molecular docking of these compounds was performed against aromatase (PDB: 3EQM), a breast cancer target. According to the findings of molecular docking experiments, compounds 2 and 11 displayed greater binding affinities in comparison to the reference medications letrozole and exemestane. The docking scores for these compounds were −7.541 and −7.934 kcal/mol, respectively. Root mean square deviation (RMSD) and root mean square fluctuation (RMSF) analysis provided further evidence that these interactions are stable. Molecular dynamics (MD) simulations provided further confirmation of this stability. The in vitro cytotoxicity experiments conducted on the MCF‐7 breast cancer cell line revealed that compounds 2 and 11 had noteworthy anticancer activity. The average inhibitory concentration (IC 50 ) values for these compounds were 21.49 ± 1.59 and 22.68 ± 3.25 µM, respectively. When compared to the values of doxorubicin (23.88 ± 2.74 µM) and letrozole (38.45 ± 3.78 µM), these values were found to be comparable, indicating that they had a great potential to inhibit cancer. Based on the data, it appears that pyrazolo[1,5‐ a ]pyrimidine derivatives have the potential to be effective lead candidates for the treatment of breast cancer by targeting aromatase inhibition. It is necessary to do more preclinical and clinical research to investigate the therapeutic potential of these proteins and their mechanism of action in the treatment of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPyrazolesAntineoplastic AgentsMolecular Docking SimulationBreast NeoplasmsHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorFemaleCell ProliferationMCF-7 CellsMolecular StructureMolecular Dynamics SimulationDose-Response Relationship, DrugAromataseAromatase Inhibitors

Stichwörter der Autor:innen

MCF‐7aromatase inhibitorsbreast cancermolecular dockingmolecular dynamicspyrazolo[1,5‐a]pyrimidine

Substanzen

PyrimidinesPyrazolesAntineoplastic Agentspyrazolo(1,5-a)pyrimidineAromataseAromatase Inhibitors

Autor:innen und Institutionen

  • Shree M. M. Patel institute of Science and Research, Kadi Serva Vishwavidyalaya, Gandhinagar, India.
  • Tolani College of Arts and Science, Adipur, India.
  • Piramal Pharma Limited, Ahmedabad, India.
  • Flamma USA LLC, Malvern, Pennsylvania, USA.
  • Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Petlad, India.
  • Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi, India.

ORCID-Profile: Umang Shah

Zitieren

APA

Patel, G., Ghumara, R., Patel, S., Shah, P., Patel, N., Lunagariya, N., Shah, P., Mali, S., Patel, M., & Shah, U. (2025). Molecular Docking, Dynamics, and Cytotoxicity Assessment of Pyrazolo[1,5‐ a ]pyrimidine Derivatives Against Breast Cancer. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501510

Vancouver

Patel G, Ghumara R, Patel S, Shah P, Patel N, Lunagariya N, et al. Molecular Docking, Dynamics, and Cytotoxicity Assessment of Pyrazolo[1,5‐ a ]pyrimidine Derivatives Against Breast Cancer. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501510

BibTeX
@article{Patel2025,
  author = {Patel, Gaurav and Ghumara, Rizwan and Patel, Sagarkumar and Shah, Pranaykumar and Patel, Niyati and Lunagariya, Nitin and Shah, Purvi and Mali, Suraj and Patel, Mehul and Shah, Umang},
  title = {Molecular Docking, Dynamics, and Cytotoxicity Assessment of Pyrazolo[1,5‐ a ]pyrimidine Derivatives Against Breast Cancer},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501510}
}
Kostenlos starten →